Memory Enhancement Using Transcranial Alternating Current Stimulation
- Conditions
- Alzheimer DiseaseMild Cognitive Impairment
- Interventions
- Device: Gamma (40 Hz) tACS at the precuneus regionDevice: Sham tACS at the precuneus region
- Registration Number
- NCT06202872
- Lead Sponsor
- Amsterdam UMC, location VUmc
- Brief Summary
The 32 million Alzheimer's disease (AD) and 69 million prodromal AD patients worldwide contribute to a large economic burden. Effective and safe therapies that slow or prevent the progression from mild cognitive impairment (MCI) to AD are therefore of high priority. Transcranial alternating current stimulation (tACS) is a safe and patient-friendly non-invasive brain stimulation technique that serves as a potential candidate for reducing and/or slowing cognitive impairment. Application of tACS in the gamma frequency range, specifically around 40 Hz, has been studied in patients with AD and MCI due to AD. In these patients, a single session of 40 Hz tACS at the precuneus showed to improve episodic memory and to increase gamma power, as measured with electroencephalography. These findings will be replicated in the current study in patients with MCI due to AD, using magnetoencephalography (MEG) recorded before, during and after tACS. In this way, brain activity and network changes that underlie this improvement in episodic memory can be studied with greater temporal and spatial detail.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 27
- Recent (not more than 6 months ago) amnestic MCI diagnosis, which consensus is obtained in a multidisciplinary meeting after an extended multidisciplinary test battery at the memory clinic, including confirmation of AD pathology with cerebrospinal fluid biomarkers: abnormal p-tau/Aβ42 ratio of > 0.023
- Suffering from serious neurological, psychiatric or somatic comorbidity
- Suffering from epileptic seizures or severe claustrophobia
- Intensive use of psychoactive medication
- Having a cardiac pacemaker, internal cardiac defibrillator or other intracorporeal device that interferes with MEG recordings
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Active tACS Gamma (40 Hz) tACS at the precuneus region Gamma (40 Hz) tACS at the precuneus region Sham tACS Sham tACS at the precuneus region Sham tACS at the precuneus region
- Primary Outcome Measures
Name Time Method Change in Rey Auditory Verbal Learning test scores Immediately before and after intervention The Rey Auditory Verbal Learning (RAVL) test evaluates verbal episodic memory and is designed as a list-learning paradigm in which the subject hears a list of 15 nouns. The participant is asked to recall as many words from the list as possible after each of 5 repetitions of free-recall (total recall), and 15 minutes after an interference trial (long delayed recall). Scores range from 0 to 75 (total recall) and 0 to 15 (long delayed recall), with higher scores meaning a better outcome. An increase in RAVL test (total and long delayed recall) after active but not sham tACS is expected.
Change in Face-Name Association Task scores Immediately before and after intervention The Face-Name Association Task assesses associative episodic memory and is a computer paradigm consisting of an encoding and a retrieval phase of face-name pairs. During the encoding phase, participants are instructed to remember a set of 12 faces and names they are paired. In two additional learning trials, participants are shown the previously learned faces and are asked to recall the correct name associated with each face (inital recognition). This recall of the correct name associated with a learned face is repeated 5 minutes after the learning trials during the retrieval phase (associative recognition). Scores range from 0 to 24 (inital recognition) and 0 to 12 (associative recognition), with higher scores meaning a better outcome. An increase in FNAT score (initial and associative recognition) after active but not sham tACS is expected.
- Secondary Outcome Measures
Name Time Method Change in functional connectivity source space resting-state MEG (PLI) Immediately before and after intervention Change in phase lag index (PLI) will be used, expecting a decrease in PLI in theta band after active but not sham tACS.
Change in source space resting-state MEG network structure (clustering coefficient and path length) Immediately before and after intervention Change in graph theory parameters will be used as a measure of global network structure. Preserved small-world configuration (shift of small world index (clustering coefficient/path length) towards less random topology) after active but not sham tACS is expected.
Change in spectral source space resting-state MEG (relative power) Immediately before and after intervention Change in relative power will be used, expecting an increase in relative power in higher alpha, beta and gamma bands and decrease in relative power in theta band after active but not sham tACS.
Change in spectral source space resting-state MEG (posterior peak frequency) Immediately before and after intervention Change in posterior peak frequency will be used, expecting an increase in posterior peak frequency after active but not sham tACS.
Change in source space resting-state MEG network structure (MST variables) Immediately before and after intervention Change in graph theory parameters will be used as a measure of global network structure. Restoration of overall network configuration (expressed by shift of multiple Minimum spanning tree (MST) parameters towards healthy state, e.g. stronger hierarchy) after active but not sham tACS is expected.
Change in source space resting-state MEG network structure (modulatory index, degree and eigenvector centrality) Immediately before and after intervention Change in graph theory parameters will be used as a measure of mesoscale network structure (modularory measures) and nodal characteristics (degree and eigenvector centrality). Restoration of hub disruption (stronger modularity index, increase in degree and eigenvector centrality) of precuneus-posterior cingulate and medial temporal lobe after active but not sham tACS is expected.
Change in functional connectivity source space resting-state MEG (AEC-c) Immediately before and after intervention Change in corrected amplitude envelope correlation (AEC-c) will be used, expecting an increase in AEC-c in higher alpha, beta and gamma bands after active but not sham tACS.
Trial Locations
- Locations (1)
Amsterdam UMC, The Netherlands
🇳🇱Amsterdam, Noord-Holland, Netherlands